CI Investments Inc’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,073
Closed -$35K 990
2025
Q3
$35K Sell
1,073
-6
-0.6% -$222 ﹤0.01% 1078
2025
Q2
$38K Sell
1,079
-4,229
-80% -$137K ﹤0.01% 1064
2025
Q1
$180K Sell
5,308
-1,719
-24% -$61.6K ﹤0.01% 758
2024
Q4
$229K Buy
7,027
+679
+11% +$28.1K ﹤0.01% 699
2024
Q3
$309K Sell
6,348
-338
-5% -$18K ﹤0.01% 566
2024
Q2
$296K Buy
6,686
+1,178
+21% +$54.3K ﹤0.01% 558
2024
Q1
$309K Buy
5,508
+1,808
+49% +$109K ﹤0.01% 577
2023
Q4
$223K Sell
3,700
-490
-12% -$31.1K ﹤0.01% 616
2023
Q3
$281K Sell
4,190
-634
-13% -$44K ﹤0.01% 552
2023
Q2
$333K Buy
4,824
+1,124
+30% +$73.4K ﹤0.01% 550
2023
Q1
$178K Buy
3,700
+1,237
+50% +$60.5K ﹤0.01% 606
2022
Q4
$123K Buy
2,463
+2,183
+780% +$106K ﹤0.01% 698
2022
Q3
$11K Sell
280
-7
-2% -$329 ﹤0.01% 1119
2022
Q2
$16K Sell
287
-437
-60% -$18.5K ﹤0.01% 999
2022
Q1
$26K Sell
724
-42
-5% -$1.66K ﹤0.01% 1038
2021
Q4
$36K Buy
+766
New +$38.9K ﹤0.01% 1045

Other funds holding LEGN

CI Investments Inc's LEGN Position: Q4 2025 in Review

CI Investments Inc sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 1,073 shares — an estimated $35K sold.

CI Investments Inc first reported a position in LEGN in Q4 2021 and held it in 16 quarters. The position peaked at $333K in Q2 2023. 200 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • CI Investments Inc reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
  • CI Investments Inc sold 1,073 Legend Biotech shares in Q4 2025, an estimated $35K.
  • CI Investments Inc first reported a position in Legend Biotech in Q4 2021 and held it in 16 quarters.
  • CI Investments Inc's Legend Biotech position peaked at $333K in Q2 2023.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on CI Investments Inc's 13F filing for Q4 2025, filed 12 Feb 2026.